Scandinavian Tobacco Group Stock Analysis: 37% Upside Case for 2026 – Institutional Research Note

Know a sophisticated investor who needs to see this?

Published: March 6, 2026Last Updated: April 1, 2026
Published: March 6, 2026Last Updated: April 1, 2026
Scandinavian Tobacco Group stock analysis

Table of Contents


Executive Summary

This Scandinavian Tobacco Group stock analysis arrives at a critical inflection point. STG announced a 47% dividend cut on 4 March 2026, sending the share price to trough valuations not seen since the company’s 2016 IPO. The question for institutional allocators is whether this represents a value trap or an asymmetric entry opportunity.

MetricValue
RecommendationHOLD / WATCHLIST
Current PriceDKK 77.00 (EUR 10.31)
Fair Value (Base Case)DKK 106 (EUR 14.19)
Margin of Safety37.6%
Wealth Preservation Score61 / 100
Dividend Yield5.8%
Probability-Weighted CAGR9.0%
Target Entry PriceDKK 65–70

The bottom line: STG is a defensible niche cigar and pipe tobacco franchise with 270+ years of heritage, trading at historic valuation lows following a dividend policy reset. Our research identifies a 5.8% yield and meaningful capital appreciation potential if Focus2030 execution delivers on margin and ROIC targets. However, the Wealth Preservation Score of 61 falls below our 65 BUY threshold, warranting patience for a superior entry point.

The key risk in a single sentence: ROIC at 7.9% sits below estimated WACC of 8–9%, indicating the company is currently destroying economic value — a condition that must reverse for the thesis to work.


Unlock the Complete Institutional Analysis

This research note is a summary of our findings. The proprietary 15-page PDF contains the full DCF model with sensitivity tables, probability-weighted scenario outputs, specific entry and exit zones, and the complete Wealth Preservation Score breakdown.

[Sign Up to Download the Full PDF Analysis →]

Your subscription could not be saved. Please try again.
Check your inbox!

Access the Full Analysis

Enter your email to receive the complete equity thesis with our valuation model and risk framework.


Investment Thesis: Why STG Demands Attention Now

Scandinavian Tobacco Group (CPH: STG) is the world’s second-largest cigar company and the global leader in pipe tobacco. Founded in 1750 and headquartered in Denmark, the company operates 14 manufacturing facilities worldwide and distributes over 200 brands — including Macanudo, CAO, Cafe Creme, Captain Black, and the recently acquired Mac Baren — to more than 100 countries.

Our Scandinavian Tobacco Group stock analysis centers on three pillars that define the investment case. The first pillar is valuation compression. STG trades at approximately 7.1x trailing earnings and 0.72x book value, representing multi-year lows driven by the 47% dividend cut from DKK 8.50 to DKK 4.50 per share. The market has over-penalized a structural dividend policy change that is actually more sustainable at a 42% payout ratio.

The second pillar is niche defensibility. Premium cigars and pipe tobacco face significantly less regulatory pressure than cigarettes, enjoy strong brand loyalty, and benefit from an artisanal consumer culture that supports pricing power. This is not a commodity tobacco business facing an existential threat from regulation.

The third pillar is strategic optionality. The Focus2030 strategy targets ROIC improvement to 11%+ from 7.9% currently, nicotine pouch expansion through the XQS brand (growing 89% in Q4 2024), and DKK 200M in cost savings. These provide multiple independent catalysts for a re-rating that could unlock substantial capital appreciation. For our full equity research archive, including comparable tobacco sector coverage, refer to the research index.


Business Quality Assessment: The Competitive Moat

STG operates as a vertically integrated manufacturer, marketer, and distributor across three segments: North America Online & Retail (direct-to-consumer via 13+ Cigars International superstores and online channels), North America Branded & Rest of World (wholesale distribution for handmade and machine-rolled cigars), and Europe Branded (wholesale distribution across key European markets).

The competitive moat in this equity research scores well on durability. The brand portfolio of 200+ brands with heritage dating to 1750 earns an 8/10 durability rating. Vertical integration across manufacturing facilities in the Dominican Republic, Honduras, Nicaragua, and the EU scores 7/10. The regulatory barrier created by FDA and PACT Act compliance requirements earns 8/10, creating meaningful barriers to entry that protect incumbent market share.

STG holds approximately 28% volume share in machine-rolled cigars across key European markets. In handmade cigars, it holds an estimated 6% volume share outside North America, making it the third-largest international player. Pricing power is moderate — demonstrated by the ability to pass through tariff-related price increases, though promotional spending has intensified in North American online channels.

The moat erosion risk is LOW-MODERATE. The premium cigar market is inherently fragmented and artisanal, but STG’s scale in machine-rolled cigars and its distribution reach provide durable competitive advantages. The primary risk is continued volume decline in European machine-rolled cigars, where share has slipped 1.8 percentage points in 2024.


Financial Fortress Analysis: Balance Sheet Deep Dive

The balance sheet in our assessment passes most critical thresholds but falls short of fortress status. Debt-to-equity at 0.65x passes the 1.0x threshold comfortably. Interest coverage at 5.0x passes but marginally. The current ratio at 1.98x provides adequate liquidity. However, cash as a percentage of total debt at just 1.8% fails the 20% threshold, and Debt/EBITDA at 2.96x passes the 3.0x ceiling by a razor-thin margin.

The solvency verdict is ADEQUATE. The balance sheet is serviceable but not a fortress. Low cash reserves and borderline interest coverage require ongoing monitoring, particularly during a period of strategic transformation.

Profitability metrics reveal a concerning trend. Gross margin has declined from 47% (5-year average) to 45.3% in FY2025. EBITDA margin compressed from 22.6% to 19.8%. Net margin dropped from 10.2% to 7.9%. FCF margin declined sharply from 10.1% to 6.6%. Every single profitability metric is trending in the wrong direction, which is the core reason our assessment assigns a HOLD rather than a BUY.

Earnings quality, however, remains HIGH. Operating cash flow has consistently tracked net income over the past five years. The FY2025 FCF shortfall of DKK 595M versus DKK 931M in FY2024 was driven by ERP-related receivables delays, which management states have been resolved. The FY2026 FCF guidance of DKK 950M–1,200M implies significant recovery and will serve as a critical validation checkpoint.


Dividend Analysis: The 47% Cut in Context

The dividend cut is the single most important development in this equity research note. On 4 March 2026, STG announced a reduction from DKK 8.50 to DKK 4.50 per share — a 47% reduction that represents a fundamental shift from a fixed progressive policy to a flexible 40–60% payout ratio against adjusted EPS.

At the new DKK 4.50 level, the yield is 5.8% at the current DKK 77 price. The payout ratio against adjusted EPS of DKK 10.80 is 42%, providing ample coverage. The FCF payout ratio stands at 60%, which is sustainable under normalized conditions.

Context matters enormously here. Despite the dividend cut, STG’s total shareholder return policy remains aggressive. The company reduced shares outstanding by 6.88% in the trailing twelve months through buybacks — the most aggressive in its peer group. Combined with the 5.8% dividend yield, the total shareholder yield is approximately 12.7%. Since the 2016 IPO, STG has returned more than DKK 9 billion to shareholders through dividends and buybacks.

Our stress test confirms the new policy’s resilience: if adjusted EPS dropped 40% to DKK 6.48, the dividend at 42% payout would be DKK 2.72, still yielding 3.5% at the current price. The dividend history spanning 10 consecutive years since IPO — including maintaining payments through 2020 at DKK 6.10 — demonstrates management’s commitment to income distribution.

The dividend sustainability verdict is SUSTAINABLE under the new policy. However, the magnitude of the cut itself is a significant negative signal that weighs heavily in our framework scoring for this research note.


Scandinavian Tobacco Group Stock Analysis: DCF Valuation and Fair Value Estimate

The valuation case in this research note is compelling on multiple metrics. STG trades at the sub-10th percentile of its 5-year P/E range at 7.1x, versus a 5-year average of 9.5x and a 10-year average of 9.0x. EV/EBITDA at 6.9x sits below the 15th percentile. Price-to-book at 0.72x is at a historic low, below the 5th percentile of its entire trading history.

Our normalized earnings approach uses a 5-year average adjusted EPS of DKK 11.50, excluding the 2025 trough. Applying a fair P/E multiple of 9.0x — based on business quality, growth trajectory, and historical median — yields a fair value of DKK 103.50. At the current price of DKK 77, this represents a 34.4% margin of safety.

On an EV/EBITDA basis, applying the 5-year average of 8.5x to FY2025 EBITDA of DKK 1,782M yields an enterprise value of DKK 15.1B. Subtracting net debt of DKK 5.36B gives equity value of DKK 9.74B, or DKK 124 per share — suggesting 61% upside. However, this higher estimate assumes earnings stabilization, which remains unproven.

The valuation verdict is ATTRACTIVE. STG is trading at or near historic lows on virtually every metric we track. Significant margin of safety exists if — and this is the critical conditional — earnings stabilize and the Focus2030 strategy begins delivering measurable results.


Probability-Weighted Scenario Modeling

Our research models three scenarios over a 10-year horizon to capture the full range of outcomes.

Bear Case (25% probability): Revenue declines at -2% CAGR, EPS contracts at -3% CAGR, terminal P/E compresses to 6.0x. Tobacco volumes continue declining at 2–3% annually. Machine-rolled cigar market share erodes further. Nicotine pouch business fails to achieve scale. ROIC remains below WACC. The 10-year price target is DKK 48, but including cumulative dividends of approximately DKK 42, the total return CAGR is 2.5%. Capital is preserved even in the bear case — a critical requirement under the wealth preservation mandate.

Base Case (50% probability): Revenue grows at +1% CAGR, EPS expands at +2% CAGR, terminal P/E recovers to 8.0x. Focus2030 delivers partial results with ROIC improving to 9–10%. The 10-year price target is DKK 106. Total return CAGR: 9.5%, comfortably exceeding the 7% minimum threshold.

Bull Case (25% probability): Revenue grows at +3% CAGR, EPS expands at +5% CAGR, terminal P/E re-rates to 10.0x. Focus2030 fully delivers with ROIC reaching 11%+. Nicotine pouches become a meaningful growth engine. The 10-year price target is DKK 176. Total return CAGR: 14.5%.

The probability-weighted expected total return across all scenarios is 9.0% CAGR — a respectable risk-adjusted return profile that outperforms the typical high-yield savings alternative by a wide margin. DKK 100 invested today becomes approximately DKK 250 over the base case horizon, versus DKK 148 in a 4% HYSA.


ROIC vs. WACC: The Value Creation Question

The ROIC analysis is the most critical component of this equity research from a wealth preservation perspective. ROIC of 7.9% is below the estimated WACC of approximately 8–9%, indicating marginal value destruction at current operating levels. This single metric is the primary reason our Wealth Preservation Score sits at 61 rather than above the 65 BUY threshold.

Management’s Focus2030 strategy targets ROIC improvement to 11%+ by 2030 through three levers: cost improvements of DKK 200M, Mac Baren synergies of DKK 150M annually, and portfolio optimization. If achieved, this would transform STG from a value destroyer into a value creator — the single most important catalyst for a re-rating.

The ROIC trajectory will be our primary monitoring metric in future updates to this research note. Quarterly improvements toward the 9% level would trigger a conviction upgrade, while sustained deterioration below 7% would trigger an exit recommendation.


Risk Matrix: 8 Dimensions of Downside

Our comprehensive risk assessment scores across eight categories. Balance sheet risk scores 4/10, reflecting moderate leverage offset by consistent FCF generation. Earnings volatility scores 5/10, driven by margin compression in FY2025 but partially mitigated by defensive product demand. Competitive threat scores 4/10 — machine-rolled cigar share losses in Europe are concerning, but brand loyalty and vertical integration provide insulation.

Regulatory risk scores 3/10, one of the lowest in tobacco, because cigars face significantly less scrutiny than cigarettes. Management risk scores 4/10 — the Focus2030 strategy is clear but execution is unproven. Valuation risk scores just 2/10, as STG is already trading at historic lows with limited further downside from multiple compression. Currency risk scores 5/10 given approximately 50% of revenue in USD. Dividend risk scores 7/10 — the highest category — reflecting the fresh 47% cut.

The aggregate risk score is 4.3/10 (MODERATE). The recession profile is RESILIENT. For comparison with other European equity research in our coverage universe, STG’s recession resilience ranks in the top quartile. STG demonstrated this during the 2020 pandemic: handmade cigar demand actually surged as consumers shifted spending to premium at-home experiences. The dividend was maintained, no equity capital was raised, and the stock recovered from DKK 62 to DKK 120+ within 18 months.


Peer Comparison: Scandinavian Tobacco Group Stock Analysis vs. Global Tobacco

This research positions STG within the broader tobacco peer group. At 7.1x P/E, STG trades roughly in line with British American Tobacco (7.5x) and below Imperial Brands (6.5x), but at a massive discount to Philip Morris International (17x). On EV/EBITDA, a similar pattern holds.

Where STG differentiates is on balance sheet strength. The 0.65x debt-to-equity ratio is dramatically lower than Philip Morris (2.5x) or Imperial Brands (2.0x). For wealth preservation mandates, this lower leverage profile provides meaningfully better downside protection. STG’s 6.88% share buyback yield is the most aggressive in the entire peer group, signaling management confidence and creating tangible per-share value accretion. For a deeper exploration of how we evaluate dividend income strategies within the wealth preservation framework, refer to our methodology documentation.

The differentiated niche exposure to premium cigars — a category with less regulatory risk and more resilient demand than cigarettes — justifies a position in portfolios seeking tobacco exposure without the existential cigarette regulation overhang. For European-based investors, the DKK-denominated Copenhagen listing avoids the currency mismatch inherent in London-listed or US-listed peers.


Management Assessment and Capital Allocation

CEO Niels Frederiksen joined STG in 1999 and was appointed CEO in 2020, bringing 25+ years of deep institutional knowledge. He has overseen the company’s transformation through multiple acquisitions including Agio, Alec Bradley, and Mac Baren, plus the launch of the nicotine pouch strategy via XQS.

Capital allocation over the past five years earns a mixed assessment in this research. Share buybacks are STRONG — reducing the float by 6.88% at depressed prices is textbook value-accretive behavior. Acquisitions are GOOD — Mac Baren (DKK 535M), Alec Bradley, and XQS are strategic bolt-on deals at manageable sizes. CapEx discipline is GOOD at DKK 155–175M annually (1.7–1.9% of revenue). Dividend policy is MIXED, given the reset from progressive to flexible.

Ownership structure provides a unique advantage. STG is ultimately controlled by two Danish foundations — the Augustinus Foundation and Det Obelske Familiefond — providing long-term, patient capital stewardship. Institutional ownership is 30.56%. This foundation-controlled structure aligns management incentives with long-term value creation rather than quarterly earnings pressure.

The management quality verdict is GOOD. Capital allocation is ACCEPTABLE.


Position Sizing and Entry Strategy

Our final recommendation in this STG equity research is HOLD / WATCHLIST with a Wealth Preservation Score of 61/100, below the 65 BUY threshold.

Three factors prevent a BUY recommendation at current levels. First, the 47% dividend cut signals management concern about near-term earnings trajectory. Cuts of this magnitude warrant a cautious approach until the new policy proves stable. Second, ROIC at 7.9% remains below estimated WACC, confirming current value destruction that must reverse. Third, the WP Score of 61 falls below our systematic threshold due to declining capital efficiency and the dividend reset.

The entry strategy is a limit order at DKK 65–70 (EUR 8.70–9.37). At that level, the yield on cost would approach 6.5–7.0%, the margin of safety would exceed 40%, and the WP Score would push above the 65 BUY threshold. Investors who acquire STG at that entry zone can expect a base case total return CAGR of approximately 9.5% over a 10-year horizon.

Upgrade triggers include: price decline to DKK 65–70, ROIC improvement to 9%+ for two consecutive quarters, dividend increase from the new DKK 4.50 base, or Focus2030 cost savings materially exceeding targets. Exit triggers include: a second consecutive dividend cut, Debt/Equity rising above 1.5x, or ROIC falling below 6% for two or more consecutive years.


Prefer a Managed Approach?

If manual portfolio construction and monitoring is not aligned with your workflow, the Quantitative Execution System automates wealth growth through a systematic, rules-based framework with a 2-year audited track record. Position sizing, rebalancing, and risk management are handled programmatically.

[Explore the Quantitative Execution System →]


Execution Infrastructure

For the institutional execution of this thesis and related equity research positions, we utilize the following platforms based on regulatory compliance, execution quality, and capital efficiency:

Primary Brokerage — Interactive Brokers: Our primary execution venue for European-listed equities. IBKR provides direct market access to Nasdaq Copenhagen (CPH) where STG is listed, with institutional-grade order routing, competitive commission structures, and multi-currency account management essential for DKK-denominated positions.

Secondary Execution — eToro: An alternative execution platform offering European equity access with social trading intelligence and commission-free structures on select instruments. Suitable for investors building initial positions or seeking fractional exposure.

Banking Infrastructure — Revolut: Multi-currency banking for EUR/DKK conversion at interbank rates, reducing the friction costs inherent in cross-border equity investment. Essential compliance infrastructure for European capital deployment.

CFD & Derivatives Access — Vantage: For investors requiring leveraged exposure or hedging capabilities on tobacco sector positions.

Digital Asset Diversification — Binance: Institutional-grade digital asset infrastructure for portfolio diversification beyond traditional equities.

Research Infrastructure — Hostinger: The hosting and technical infrastructure powering the Moschovakis Capital research platform and subscriber-facing analytics dashboards.


Risk Disclaimer

This Scandinavian Tobacco Group stock analysis is published by Moschovakis Capital for informational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. The analyst may hold positions in securities discussed. Readers should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. Currency conversions at DKK/EUR = 7.47 (4 March 2026).

About the Author

Angelos Moschovakis is the founder and lead analyst at Moschovakis Capital, an independent financial research and trading technology firm based in Athens, Greece. With over seven years of experience investing personal capital across FX and global equities, Angelos holds eToro Popular Investor status and maintains a 24-month independently audited trading record via Myfxbook and MQL5. All equity positions are publicly visible on his eToro portfolio.

Disclosure: Angelos Moschovakis and/or Moschovakis Capital may hold positions in securities discussed in this analysis. Positions may be acquired or disposed of at any time, including before or after publication. Current holdings are publicly visible on the Moschovakis Capital eToro portfolio.

Important: This analysis is published for educational and informational purposes only. Moschovakis Capital is a financial technology provider and independent research publisher — not a licensed financial advisor. Nothing in this article constitutes personalized investment advice. Past performance does not guarantee future results. Please read our full Risk Disclosure before acting on any information provided here. All stocks are evaluated using the WP Score framework →

Related Research

Related Research


Know a sophisticated investor who needs to see this?
Moschovakis Capital · Athens, Greece · contact@moschovakiscapital.com